Literature DB >> 20561060

Association of the GABRD gene and childhood-onset mood disorders.

Y Feng1, K Kapornai, E Kiss, Z Tamás, L Mayer, I Baji, G Daróczi, I Benák, V O Kothencné, E Dombovári, E Kaczvinszk, M Besnyo, J Gádoros, J Székely, M Kovacs, A Vetró, J L Kennedy, C L Barr.   

Abstract

The chromosome 1p36 region was previously indicated as a locus for susceptibility to recurrent major depressive disorder based on a linkage study in a sample of 497 sib pairs. We investigated the gamma-aminobutyric acid A (GABA(A)) delta receptor subunit gene, GABRD, as a susceptibility gene to childhood-onset mood disorders (COMD) because of substantial evidence implicating GABAergic dysfunction in mood disorders and the position of this gene near the 1p36 linkage region. Using a sample consisting of 645 Hungarian families with a child/adolescent proband diagnosed with a mood disorder with the onset of the first episode before age 15, we found some evidence for the association of two polymorphisms located within the gene, rs2376805 and rs2376803, as well as significant evidence for biased transmission of the haplotypes of these two markers (global chi(2) test for haplotypes = 12.746, 3 df, P = 0.0052). Furthermore, significant evidence of association was only observed in male subjects (n = 438) when the results were analyzed by sex (chi(2) = 9.000 1 df, P = 0.003 for rs2376805). This was in contrast with the previous linkage findings, as LOD scores exceeding 3 were only in female-female pairs in that study. These findings point to the GABRD gene as a susceptibility gene for COMD; however, this gene may not explain the previous linkage finding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561060      PMCID: PMC2935687          DOI: 10.1111/j.1601-183X.2010.00598.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  29 in total

1.  Early developmental characteristics and features of major depressive disorder among child psychiatric patients in Hungary.

Authors:  Krisztina Kapornai; Amy L Gentzler; Ping Tepper; Eniko Kiss; László Mayer; Zsuzsanna Tamás; Maria Kovacs; Agnes Vetró
Journal:  J Affect Disord       Date:  2006-11-20       Impact factor: 4.839

Review 2.  Genetics of affective (mood) disorders.

Authors:  Nick Craddock; Liz Forty
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

Review 3.  GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.

Authors:  Tija C Jacob; Stephen J Moss; Rachel Jurd
Journal:  Nat Rev Neurosci       Date:  2008-05       Impact factor: 34.870

4.  Clinical features of depressed children and adolescents with various forms of suicidality.

Authors:  Xianchen Liu; Amy L Gentzler; Ping Tepper; Enikö Kiss; Viola Osváth Kothencné; Zsuzsanna Tamás; Agnes Vetró; Maria Kovacs
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

5.  Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty.

Authors:  Hui Shen; Qi Hua Gong; Chiye Aoki; Maoli Yuan; Yevgeniy Ruderman; Michael Dattilo; Keith Williams; Sheryl S Smith
Journal:  Nat Neurosci       Date:  2007-03-11       Impact factor: 24.884

6.  Neuroactive steroids as modulators of depression and anxiety.

Authors:  D Eser; E Romeo; T C Baghai; F di Michele; C Schüle; A Pasini; P Zwanzger; F Padberg; R Rupprecht
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

7.  Factors influencing mother-child reports of depressive symptoms and agreement among clinically referred depressed youngsters in Hungary.

Authors:  Eniko Kiss; Amy M Gentzler; Charles George; Krisztina Kapornai; Zsuzsanna Tamás; Maria Kovacs; Agnes Vetró
Journal:  J Affect Disord       Date:  2006-11-27       Impact factor: 4.839

Review 8.  The complex roles of neurosteroids in depression and anxiety disorders.

Authors:  Patrizia Longone; Rainer Rupprecht; Gaia A Manieri; Giorgio Bernardi; Elena Romeo; Augusto Pasini
Journal:  Neurochem Int       Date:  2007-10-06       Impact factor: 3.921

9.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Authors:  Gregor Hasler; Jan Willem van der Veen; Toni Tumonis; Noah Meyers; Jun Shen; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2007-02

10.  The relations of temperament and emotion self-regulation with suicidal behaviors in a clinical sample of depressed children in Hungary.

Authors:  Zsuzsanna Tamás; Maria Kovacs; Amy L Gentzler; Ping Tepper; Júlia Gádoros; Eniko Kiss; Krisztina Kapornai; Agnes Vetró
Journal:  J Abnorm Child Psychol       Date:  2007-05-25
View more
  22 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 2.  Interneuronal GABAA receptors inside and outside of synapses.

Authors:  Isabella Ferando; Istvan Mody
Journal:  Curr Opin Neurobiol       Date:  2013-12-29       Impact factor: 6.627

3.  In vitro gamma oscillations following partial and complete ablation of δ subunit-containing GABAA receptors from parvalbumin interneurons.

Authors:  Isabella Ferando; Istvan Mody
Journal:  Neuropharmacology       Date:  2014-09-28       Impact factor: 5.250

Review 4.  Phosphorylation of GABAA receptors influences receptor trafficking and neurosteroid actions.

Authors:  Eydith Comenencia-Ortiz; Stephen J Moss; Paul A Davies
Journal:  Psychopharmacology (Berl)       Date:  2014-05-22       Impact factor: 4.530

5.  Dysfunctional astrocytic and synaptic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: relevance to neurosteroids and programming of the stress response.

Authors:  Benjamin G Gunn; Linda Cunningham; Michelle A Cooper; Nicole L Corteen; Mohsen Seifi; Jerome D Swinny; Jeremy J Lambert; Delia Belelli
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

6.  Regulation of the surface expression of α4β2δ GABAA receptors by high efficacy states.

Authors:  Aarti Kuver; Hui Shen; Sheryl S Smith
Journal:  Brain Res       Date:  2012-05-02       Impact factor: 3.252

7.  A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder.

Authors:  Honglei Yin; Spiro P Pantazatos; Hanga Galfalvy; Yung-Yu Huang; Gorazd B Rosoklija; Andrew J Dwork; Ainsley Burke; Victoria Arango; Maria A Oquendo; John J Mann
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-19       Impact factor: 3.568

8.  Chemogenetic Isolation Reveals Synaptic Contribution of δ GABAA Receptors in Mouse Dentate Granule Neurons.

Authors:  Min-Yu Sun; Hong-Jin Shu; Ann Benz; John Bracamontes; Gustav Akk; Charles F Zorumski; Joe Henry Steinbach; Steven J Mennerick
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

9.  Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies.

Authors:  Anup Sharma; Andrew B Newberg
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2015

10.  Flumazenil decreases surface expression of α4β2δ GABAA receptors by increasing the rate of receptor internalization.

Authors:  Aarti Kuver; Sheryl S Smith
Journal:  Brain Res Bull       Date:  2015-11-22       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.